| Sumoylation pathway is required to maintain the basal breast cancer subtype MV Bogachek, Y Chen, MV Kulak, GW Woodfield, AR Cyr, JM Park, ... Cancer cell 25 (6), 748-761, 2014 | 94 | 2014 |
| Hypoxia perturbs aryl hydrocarbon receptor signaling and CYP1A1 expression induced by PCB 126 in human skin and liver-derived cell lines SU Vorrink, PL Severson, MV Kulak, BW Futscher, FE Domann Toxicology and applied pharmacology 274 (3), 408-416, 2014 | 88 | 2014 |
| Transcriptional regulation of the GPX1 gene by TFAP2C and aberrant CpG methylation in human breast cancer MV Kulak, AR Cyr, GW Woodfield, M Bogachek, PM Spanheimer, T Li, ... Oncogene 32 (34), 4043-4051, 2013 | 75 | 2013 |
| TFAP2C governs the luminal epithelial phenotype in mammary development and carcinogenesis AR Cyr, MV Kulak, JM Park, MV Bogachek, PM Spanheimer, ... Oncogene 34 (4), 436-444, 2015 | 66 | 2015 |
| Inhibiting the SUMO pathway represses the cancer stem cell population in breast and colorectal carcinomas MV Bogachek, JM Park, JP De Andrade, AW Lorenzen, MV Kulak, ... Stem cell reports 7 (6), 1140-1151, 2016 | 64 | 2016 |
| Measles cases in highly vaccinated population of Novosibirsk, Russia, 2000–2005 AV Atrasheuskaya, MV Kulak, AA Neverov, S Rubin, GM Ignatyev Vaccine 26 (17), 2111-2118, 2008 | 59 | 2008 |
| Mumps vaccine failure investigation in Novosibirsk, Russia, 2002–2004 AV Atrasheuskaya, MV Kulak, S Rubin, GM Ignatyev Clinical microbiology and infection 13 (7), 670-676, 2007 | 51 | 2007 |
| A novel HER2 gene body enhancer contributes to HER2 expression Q Liu, MV Kulak, N Borcherding, PK Maina, W Zhang, RJ Weigel, HH Qi Oncogene 37 (5), 687-694, 2018 | 45 | 2018 |
| Inhibition of RET increases the efficacy of antiestrogen and is a novel treatment strategy for luminal breast cancer PM Spanheimer, JM Park, RW Askeland, MV Kulak, GW Woodfield, ... Clinical cancer research 20 (8), 2115-2125, 2014 | 45 | 2014 |
| Genetic and biological characterization of avian influenza H5N1 viruses isolated from wild birds and poultry in Western Siberia K Sharshov, A Romanovskaya, R Uzhachenko, A Durymanov, ... Archives of virology 155 (7), 1145-1150, 2010 | 43 | 2010 |
| Investigation of mumps vaccine failures in Minsk, Belarus, 2001–2003 AV Atrasheuskaya, EM Blatun, MV Kulak, A Atrasheuskaya, IA Karpov, ... Vaccine 25 (24), 4651-4658, 2007 | 43 | 2007 |
| EGFR is regulated by TFAP2C in luminal breast cancer and is a target for vandetanib JP De Andrade, JM Park, VW Gu, GW Woodfield, MV Kulak, AW Lorenzen, ... Molecular cancer therapeutics 15 (3), 503-511, 2016 | 37 | 2016 |
| Human Melanoma cells over-express extracellular matrix 1 (ECM1) which is regulated by TFAP2C G Lal, PG Contreras, M Kulak, G Woodfield, T Bair, FE Domann, ... PloS one 8 (9), e73953, 2013 | 32 | 2013 |
| Expression of the RET Proto-oncogene Is Regulated by TFAP2C in Breast Cancer Independent of the Estrogen Receptor PM Spanheimer, GW Woodfield, AR Cyr, MV Kulak, LS White-Baer, ... Annals of surgical oncology 20, 2204-2212, 2013 | 28 | 2013 |
| Receptor tyrosine kinase expression predicts response to sunitinib in breast cancer PM Spanheimer, AW Lorenzen, JP De Andrade, MV Kulak, JC Carr, ... Annals of surgical oncology 22, 4287-4294, 2015 | 25 | 2015 |
| TFAP2C regulates carbonic anhydrase XII in human breast cancer CM Franke, VW Gu, BG Grimm, VC Cassady, JR White, RJ Weigel, ... Oncogene 39 (6), 1290-1301, 2020 | 23 | 2020 |
| Surveillance and identification of influenza A viruses in wild aquatic birds in the Crimea, Ukraine (2006–2008) MV Kulak, FA Ilinykh, AV Zaykovskaya, AV Epanchinzeva, IL Evstaphiev, ... Avian diseases 54 (3), 1086-1090, 2010 | 21 | 2010 |
| A TFAP2C Gene Signature Is Predictive of Outcome in HER2-Positive Breast Cancer VT Wu, B Kiriazov, KE Koch, VW Gu, AC Beck, N Borcherding, T Li, ... Molecular cancer research 18 (1), 46-56, 2020 | 20 | 2020 |
| AP-2α–Mediated Activation of E2F and EZH2 Drives Melanoma Metastasis JR White, DT Thompson, KE Koch, BS Kiriazov, AC Beck, ... Cancer research 81 (17), 4455-4470, 2021 | 19 | 2021 |
| AP-2α regulates S-phase and is a marker for sensitivity to PI3K inhibitor buparlisib in colon cancer AC Beck, E Cho, JR White, L Paemka, T Li, VW Gu, DT Thompson, ... Molecular cancer research 19 (7), 1156-1167, 2021 | 15 | 2021 |
